EPM2A antibody (AA 131-144)
-
- Target See all EPM2A Antibodies
- EPM2A (Epilepsy, Progressive Myoclonus Type 2A, Lafora Disease (Laforin) (EPM2A))
-
Binding Specificity
- AA 131-144
- Reactivity
- Human, Rat, Mouse, Cow, Dog, Pig, Rabbit, Monkey, Bat
-
Host
- Goat
-
Clonality
- Polyclonal
-
Conjugate
- This EPM2A antibody is un-conjugated
-
Application
- Western Blotting (WB), ELISA, Immunohistochemistry (IHC), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))
- Brand
- IHC-plus™
- Specificity
- Human EPM2A. This antibody is expected to recognize isoform a (NP_005661.1) only.
- Predicted Reactivity
- Percent identity by BLAST analysis: Human, Gibbon, Monkey, Marmoset, Mouse, Rat, Elephant, Panda, Bovine, Bat, Dog, Rabbit, Pig, Opossum (100%) Xenopus (93%).
- Purification
- Immunoaffinity purified
- Immunogen
-
Synthetic peptide C-EATGHTNEMKHTTD from an internal region of human EPM2A (NP_005661.1). Percent identity by BLAST analysis: Human, Gibbon, Monkey, Marmoset, Mouse, Rat, Elephant, Panda, Bovine, Bat, Dog, Rabbit, Pig, Opossum (100%), Xenopus (93%).
Type of Immunogen: Synthetic peptide - Top Product
- Discover our top product EPM2A Primary Antibody
-
-
- Application Notes
-
Approved: IHC, IHC-P (2.5 - 3.75 μg/mL), Peptide-ELISA (1:16000, 0.1 - 0.3 μg/mL), WB (0.1 - 0.3 μg/mL)
Usage: Peptide ELISA: antibody detection limit dilution 1:16000. Western Blot: Approx. 38kD band observed in Human Brain (Cerebellum), Mouse Brain and Rat Brain lysates (calculated MW of 37.2kD according to NP_005661.1). Recommended concentration: 0.1-0.3 μg/mL. - Comment
-
Target Species of Antibody: Human
- Restrictions
- For Research Use only
-
- Format
- Liquid
- Concentration
- Lot specific
- Buffer
- Tris-buffered saline, pH 7.3, 0.5 % BSA, 0.02 % sodium azide
- Preservative
- Sodium azide
- Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Handling Advice
- Minimize freezing and thawing.
- Storage
- -20 °C
- Storage Comment
- Store at -20°C. Avoid freeze-thaw cycles.
-
- Target
- EPM2A (Epilepsy, Progressive Myoclonus Type 2A, Lafora Disease (Laforin) (EPM2A))
- Alternative Name
- EPM2A / Laforin (EPM2A Products)
- Synonyms
- TG-B antibody, Tg(TcraK,TcrbK)TG-BFlv antibody, EPM2 antibody, MELF antibody, laforin antibody, EPM2A, laforin glucan phosphatase antibody, epilepsy, progressive myoclonic epilepsy, type 2 gene alpha antibody, EPM2A antibody, Epm2a antibody
- Background
-
Name/Gene ID: EPM2A
Subfamily: Laforin
Family: Protein Phosphatase
Synonyms: EPM2A, EPM2, LAFPTPase, LDE, Lafora PTPase, MELF, Laforin, LD - Gene ID
- 7957
- NCBI Accession
- NP_005661
- UniProt
- O95278
- Pathways
- Cellular Glucan Metabolic Process
-